European Market Report for Implantable Ports 2017 - MedCore

  • ID: 3960399
  • Report
  • Region: Europe
  • 134 pages
  • iData Research
1 of 5


  • 3DT Holdings LLC
  • Bionic
  • Edwards Lifesciences
  • LPI
  • Perouse Medical
  • Smiths Medical
  • MORE
Implantable ports are reservoirs that are implanted into the body and connected to the superior vena cava (SVC) by a catheter. These devices require an invasive surgical implantation by vascular surgeons or interventional radiologists. Ports provide long-term treatment ranging from several months to several years. There are implantable ports for the torso and the arms; however, the arm port market is limited by its history of technical problems. Patients undergoing long-term treatments often opt for implantable ports, as the devices are less visible, more comfortable and more convenient than chronic central venous catheters (CVCs) or peripherally inserted central catheters (PICCs).

Depending on treatment, patients with certain models of implantable ports can receive a constant flow of medication, or a single large dose on a regular basis. In addition, implantable ports are associated with several benefits including fewer complications, a lower infection risk in comparison to CVCs and PICCs, as well as a higher level of patient satisfaction. However, infections and other complications remain a serious concern. Moreover, from the three main venous access devices: CVCs, PICCs and ports, ports are the most expensive device and require a more complicated insertion procedure.
Note: Product cover images may vary from those shown
2 of 5


  • 3DT Holdings LLC
  • Bionic
  • Edwards Lifesciences
  • LPI
  • Perouse Medical
  • Smiths Medical
  • MORE
Table Of Contents I
List Of Figures Xvii
List Of Charts Xxi
Executive Summary
European Market For Vascular Access Devices And Accessories Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History
Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring
Disease Overview
2.1 Basic Anatomy
2.1.1 Human Vascular System
2.2 Vascular Pathology And Disorders
2.2.1 Cancer
2.2.2 End-Stage Renal Disease
2.2.3 Diabetes
Product Assessment
3.1 Product Portfolios
3.1.1 Implantable Port Devices Introduction Implantable Port Patients Port Implantation Procedures Port Infusion Port Maintenance Angiodynamics Bioflo® Lifeport® Smart Port® Ct Titanport® Triumph-1® Vortex® Xcela™ Plus B. Braun Celsite® Cook Medical Vital-Port® C.R. Bard Powerport® Slimport® X-Port™ Other Port Offerings Medcomp Dignity® Pro-Fuse® Ct Pfm Medical T-Port™ Titajet™ Jet Port® Dualport Smiths Medical P.A.S. Port® Port-A-Cath® Teleflex Medical Polysite®
3.2 Regulatory Issues And Recalls
3.2.1 November 2015
3.2.2 October 2015
3.2.3 September 2015
3.2.4 August 2015
3.2.5 July 2015
3.2.6 April 2015
3.2.7 March 2015
3.2.8 February 2015
3.2.9 January 2015
3.2.10 December 2014
3.2.11 October 2014
3.2.12 September 2014
3.2.13 May 2014
3.2.14 April 2014
3.2.15 March 2014
3.2.16 January 2014
3.2.17 December 2013
3.2.18 September 2013
3.2.19 August 2013
3.2.20 June 2013
3.2.21 March 2013
3.2.22 February 2013
3.2.23 December 2012
3.2.24 August 2012
3.2.25 June 2012
3.2.26 May 2012
3.2.27 March 2012
3.2.28 February 2012
3.2.29 January 2012
3.3 Clinical Trials
3.3.1 Implantable Port Devices
3.4 Product Pipelines
3.4.1 Alliance Vascular Devices, Llc Freehand Safety Huber Needle®
3.4.2 Angiodynamics Celerity™ Picc Tip Confirmation System With Navigation Firefly Bioflo® Picc Line Extension Bioflo® Port Line Extension Next Generation Bioflo® Picc Next Generation Bioflo® Port
3.4.3 Bluegrass Vascular Technologies, Inc. Surfacer® Inside-Out™ Access System
3.4.4 C.R. Bard Chemical-Resistant Piccs Novel Advanced Material Piccs Powerglide® Pro Midline Accucath® Xenesis™ Acute Hemodialysis Catheter Site~Rite® 8 Ultrasound System
3.4.5 M. C. Johnson Picc Securement Device
3.4.6 Nipro Medical Shielding Safety Needle Safety Syringe Safety Pivc
3.4.7 Parasol Medical Catheter Securement Device
3.4.8 Pavmed Inc. Nextcath™
3.4.9 Phase One Medical Goldilocks™ Long Term Hemodialysis Catheter Triple-Lumen Symetrex™ Hemodialysis Catheter
3.4.10 Prodigy Diabetes Care, Llc. Insulin Pen Needles
3.4.11 Sharklet Technologies, Inc. Sharklet™ Central Venous Catheter
3.4.12 Starboard Medical Catheter Securement Devices
3.4.13 Teleflex Medical Arrow® Endurance™ Extended Dwell Peripheral Catheter System Tip Confirmation For Cvcs, Chronic Hemodialysis Catheters & Ports
3.4.14 Vascular Access Technologies, Inc. Safecvad™
Country Profiles
4.1 Introduction
4.1.1 Population
4.1.2 Gdp Per Capita
4.1.3 Price Index
4.2 Germany
4.3 France
4.4 United Kingdom
4.5 Italy
4.6 Spain
4.7 Benelux
4.8 Scandinavia
4.9 Austria
4.10 Switzerland
4.11 Portugal
Implantable Port Market
5.1 Introduction
5.1.1 Implantable Port Patients
5.1.2 Port Implantation Procedures
5.1.3 Port Infusion
5.1.4 Port Maintenance
5.1.5 Power Ports
5.2 Market Overview
5.3 Market Analysis And Forecast
5.3.1 Total Implantable Port Market
5.3.2 Conventional Implantable Port Market Single-Lumen Conventional Implantable Port Market Double-Lumen Conventional Implantable Port Market
5.3.3 Power-Injectable Implantable Port Market Single-Lumen Power-Injectable Implantable Port Market Double-Lumen Power-Injectable Implantable Port Market
5.4 Drivers And Limiters
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 Competitive Market Share Analysis
Appendix Ii: Company Press Releases
Note: Product cover images may vary from those shown
3 of 5


4 of 5


  • 3DT Holdings LLC
  • Bionic
  • Edwards Lifesciences
  • LPI
  • Perouse Medical
  • Smiths Medical
  • MORE
The implantable port market comprises conventional and power-injectable implantable ports. Power-injectable implantable ports are capable of withstanding higher pressures than conventional implantable ports in order to facilitate the injection of contrast dye for computed tomography (CT) scan procedures. If a patient has a conventional implantable port and requires a medical scan, the port must be removed and replaced with a power-injectable port.
Note: Product cover images may vary from those shown
5 of 5
3DT Holdings LLC
Access Scientific
Ambu Inc.
B. Braun
Baxter International
Becton Dickinson
C. R. Bard
Cardinal Health
Cook Medical
Districlass Medical
Edwards Lifesciences
Endeavor Capital
Grupo Sendal
Interrad Medical
Ivera Medical Corporation
Navilyst Medical
Nipro Medical
Nostix, LLC
Perouse Medical
PFM Medical
PFM Medical
PositiveID Corp.
Roundtable Healthcare
Safety Syringes Inc.
Semprus BioSciences
Smiths Medical
SonoSite, Inc.
Teleflex Medical
Vascular Pathways, Inc.
VeriTeQ Acquisition Corp.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown